No association between c-myc amplification and TP53 mutation in sarcoma tumorigenesis
- 31 August 1994
- journal article
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 76 (1) , 47-49
- https://doi.org/10.1016/0165-4608(94)90070-1
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Clinicopathologic Correlations and Short-Term Prognosis in Musculoskeletal Sarcoma with c-myc Oncogene AmplificationAmerican Journal of Clinical Oncology, 1994
- Amplification of the c-myc Proto-Oncogene in Soft Tissue SarcomasOncology, 1994
- Lack of allelic deletion and point mutation as mechanisms of p53 activation in human malignant melanomaInternational Journal of Cancer, 1993
- Amplification of c‐myc oncogene and absence of c‐Ha‐ras point mutation in human bone sarcomaJournal of Orthopaedic Research, 1993
- Structural and functional analysis of oncogenes and tumor suppressor genes in adult T-cell leukemia/lymphoma shows frequent p53 mutationsBlood, 1992
- Quantitation of biological tumor markers (p53, c‐myc, Ki‐67 and DNA ploidy) by multiparameter flow cytometry in non‐small‐cell lung cancerInternational Journal of Cancer, 1992
- Inactivation of p53 gene in human and murine osteosarcoma cellsBritish Journal of Cancer, 1992
- p53 Mutations in Human CancersScience, 1991
- Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reactionGenomics, 1989
- The Approaching Era of the Tumor Suppressor GenesScience, 1987